All Stories

  1. Experience Using a New High-Density Polyethylene-Based Porous Orbital Implant: Explorative 1-Year Performance and Safety Results
  2. Long-Term Mental Health after High-Density Polyethylene-Based Porous Orbital Implant in Enucleated and Eviscerated Patients
  3. Role of Nutrients Regulating Myeloid Derived Suppressor Cells in Cancer: A Scoping Review
  4. The Expression of Genes Related to Reverse Cholesterol Transport and Leptin Receptor Pathways in Peripheral Blood Mononuclear Cells Are Decreased in Morbid Obesity and Related to Liver Function
  5. Influence of the Surface Topography of Titanium Dental Implants on the Behavior of Human Amniotic Stem Cells
  6. Role of Leptin in Obesity, Cardiovascular Disease, and Type 2 Diabetes
  7. Cancer Nano-Immunotherapy: The Novel and Promising Weapon to Fight Cancer
  8. Tissue-specific Activated Regulatory Lymphocytes Immunophenotype in Chronic Rhinosinusitis with Nasal Polyps
  9. Defining the Emergence of New Immunotherapy Approaches in Breast Cancer: Role of Myeloid-Derived Suppressor Cells
  10. Role of Leptin as a Link between Asthma and Obesity: A Systematic Review and Meta-Analysis
  11. Obesity and Risk for Lymphoma: Possible Role of Leptin
  12. Pembrolizumab in combination with gemcitabine for patients with HER2-negative advanced breast cancer: GEICAM/2015–04 (PANGEA-Breast) study
  13. The effects of dendritic cell-based vaccines in the tumor microenvironment: Impact on myeloid-derived suppressor cells
  14. Ewing Sarcoma Meets Epigenetics, Immunology and Nanomedicine: Moving Forward into Novel Therapeutic Strategies
  15. Decreased Expression of Sam68 Is Associated with Insulin Resistance in Granulosa Cells from PCOS Patients
  16. Obesity as a Risk Factor for Dementia and Alzheimer’s Disease: The Role of Leptin
  17. Tumor Immune Microenvironment in Lymphoma: Focus on Epigenetics
  18. Leptin in Dental Pulp and Periapical Tissues: A Narrative Review
  19. Nutrients and Dietary Approaches in Patients with Type 2 Diabetes Mellitus and Cardiovascular Disease: A Narrative Review
  20. Possible Role of Leptin in Atopic Dermatitis: A Literature Review
  21. Increased Blood Monocytic Myeloid Derived Suppressor Cells but Low Regulatory T Lymphocytes in Patients with Mild COVID-19
  22. Pembrolizumab Plus Gemcitabine in the Subset of Triple-Negative Advanced Breast Cancer Patients in the GEICAM/2015-04 (PANGEA-Breast) Study
  23. Lower Survival and Increased Circulating Suppressor Cells in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma with Deficit of Vitamin D Levels Using R-GDP Plus Lenalidomide (R2-GDP): Results from the R2-GDP-GOTEL Trial
  24. Publisher Correction: Circulating immune biomarkers in peripheral blood correlate with clinical outcomes in advanced breast cancer
  25. Circulating immune biomarkers in peripheral blood correlate with clinical outcomes in advanced breast cancer
  26. Role of Leptin in Non-Alcoholic Fatty Liver Disease
  27. Leptin, Both Bad and Good Actor in Cancer
  28. Role of Leptin in Inflammation and Vice Versa
  29. Leptin and Nutrition in Gestational Diabetes
  30. Leptin and Gestational Diabetes Mellitus
  31. Postprandial triglyceride-rich lipoproteins promote M1/M2 microglia polarization in a fatty-acid-dependent manner
  32. Aquaporins and placenta
  33. Maternal diet modulates placental nutrient transporter gene expression in a mouse model of diabetic pregnancy
  34. Screening for Gestational Diabetes Mellitus by Measuring Glycated Hemoglobin Can Reduce the Use of the Glucose Challenge Test
  35. Automated urinalysis combining physicochemical analysis, on-board centrifugation, and digital imaging in one system: A multicenter performance evaluation of the cobas 6500 urine work area
  36. Pitfalls of ABO Genotyping Based on Targeted Single Nucleotide Variant Analysis Due to a Nondeletional O Allele Lacking c.261delG: First Report of ABO*O.09.01 in Korea
  37. Human amniotic membrane conditioned medium inhibits proliferation and modulates related microRNAs expression in hepatocarcinoma cells
  38. ROLE OF LEPTIN ON THE APOPTOSIS OF TROPHOBLAST EXPLANTS TRIGGERED BY ACIDOSIS
  39. Obesity and Breast Cancer: Role of Leptin
  40. Myeloid derived-suppressor cells in healthy women and in advanced breast cancer patients
  41. First-trimester proteomic profiling identifies novel predictors of gestational diabetes mellitus
  42. Circulating regulatory T cells from breast cancer patients in response to neoadjuvant chemotherapy
  43. Leptin stimulates DMP-1 and DSPP expression in human dental pulp via MAPK 1/3 and PI3K signaling pathways
  44. Leptin protects placental cells from apoptosis induced by acidic stress
  45. New horizons in breast cancer: the promise of immunotherapy
  46. Diabetes mellitus y riesgo cardiovascular. Actualización de las recomendaciones del Grupo de Trabajo de Diabetes y Riesgo Cardiovascular de la Sociedad Española de Diabetes (SED, 2018)
  47. Placental leptin expression is mediated by NFκB signaling
  48. Proliferation and survival of human amniotic epithelial cells during their hepatic differentiation
  49. Fasting Glycemia as Screening Tool to Rule-Out Gestational Diabetes in Low-Risk Population
  50. Leptin action in normal and pathological pregnancies
  51. Involvement of leptin in the molecular physiology of the placenta
  52. Leptin upregulates aquaporin 9 expression in human placenta in vitro
  53. Human amniotic epithelial cells: evaluation of survival during their hepatic differentiation
  54. Transcription factors involved in estradiol leptin induction in placenta
  55. Sp1 transcription factor is a modulator of estradiol leptin induction in placental cells
  56. The impact of systems-of-care on pharmacoinvasive management with streptokinase: The subgroup analysis of the TN-STEMI programme
  57. MgO-based adsorbents for CO2 adsorption: Influence of structural and textural properties on the CO2 adsorption performance
  58. Role of leptin as a link between metabolism and the immune system
  59. Inhibition of HMGB1 protects the retina from ischemia-reperfusion, as well as reduces insulin resistance proteins
  60. A System of Care for Patients With ST-Segment Elevation Myocardial Infarction in India
  61. Cardiological Society of India: Position statement for the management of ST elevation myocardial infarction in India
  62. Amniotic membrane conditioned medium promotes cell death and inhibits proliferation of hepatocarcinoma HepG2 cells
  63. Role of leptin in the molecular physiology of the placenta
  64. Action and Mechanisms of Action of the Chromogranin A Derived Peptide Pancreastatin
  65. Breast Cancer Immunology and Immunotherapy
  66. Comparison of Citrate Buffer with Sodium Fluoride as Additives in Determining Glycemia
  67. Pancreastatin Signaling. Mechanisms of Action ☆
  68. Pancreastatin, a Regulatory Peptide Derived From Chromogranin A ☆
  69. Prevalence of parameters of suboptimal scaffold deployment following angiographic guided bioresorbable vascular scaffold implantation in real world practice - an optical coherence tomography analysis
  70. A case of recurrent unstable angina – Insight from optical coherence tomography imaging
  71. Sam68 Mediates the Activation of Insulin and Leptin Signalling in Breast Cancer Cells
  72. Leptin reduces apoptosis triggered by high temperature in human placental villous explants: The role of the p53 pathway
  73. Diabetes mellitus y riesgo cardiovascular: recomendaciones del Grupo de Trabajo Diabetes y Enfermedad Cardiovascular de la Sociedad Española de Diabetes (SED, 2015)
  74. Increased Expression of Aquaporin 9 in Trophoblast From Gestational Diabetic Patients
  75. Risk Factors for Hyperglycaemia in Pregnancy in Tamil Nadu, India
  76. Two-year follow-up data from the STEPP-AMI study: A prospective, observational, multicenter study comparing tenecteplase-facilitated PCI versus primary PCI in Indian patients with STEMI
  77. Insulin and Leptin Signaling in Placenta from Gestational Diabetic Subjects
  78. Mechanisms involved in p53 downregulation by leptin in trophoblastic cells
  79. Framework for a National STEMI Program: Consensus document developed by STEMI INDIA, Cardiological Society of India and Association Physicians of India
  80. Aortic Stiffness and Cardiovascular Risk in Women with Previous Gestational Diabetes Mellitus
  81. Diabetes mellitus y riesgo cardiovascular: recomendaciones del Grupo de Trabajo Diabetes y Enfermedad Cardiovascular de la Sociedad Española de Diabetes (SED, 2015)
  82. Evaluation of a HbA1c point-of-care analyzer
  83. Association between Obesity Indices and Insulin Resistance among Healthy Korean Adolescents: The JS High School Study
  84. Evaluation of the Nova StatSensor® XpressTM Creatinine Point-Of-Care Handheld Analyzer
  85. Testing Pancreatic Islet Function at the Single Cell Level by Calcium Influx with Associated Marker Expression
  86. Protective effect of leptin on the apoptosis of trophoblast explants triggered by high temperature
  87. Antiapoptotic effects of leptin on trophoblasts
  88. Human amniotic epithelial cells: Proliferation and apoptosis during their hepatic differentiation
  89. Leptin is involved in human trophoblast migration and invasion
  90. Role of Sam68 in leptin and insulin signaling in granulosa cells
  91. Leptin promotes HLA-G expression on placental trophoblasts via the MEK/Erk and PI3K signaling pathways
  92. Leptin Promotes Dentin Sialophosphoprotein Expression in Human Dental Pulp
  93. Role of leptin in female reproduction
  94. Expression and immunohistochemical localization of leptin in human periapical granulomas
  95. GSK3β Is Increased in Adipose Tissue and Skeletal Muscle from Women with Gestational Diabetes Where It Regulates the Inflammatory Response
  96. Reference Intervals for N-Terminal Pro-B-Type Natriuretic Peptide in Amniotic Fluid between 10 and 34 Weeks of Gestation
  97. Leptin Downregulates Aggrecan through the p38-ADAMST Pathway in Human Nucleus Pulposus Cells
  98. Expression and immunohistochemical localization of leptin receptor in human periapical granuloma
  99. Pathological Complete Response and Changes Related to T Infiltrating Lymphocytes and Regulatory T Cells in Tissue and Peripheral Blood After Neoadjuvant Chemotherapy in Breast Carcinoma
  100. Leptin Is an Anti-Apoptotic Effector in Placental Cells Involving p53 Downregulation
  101. Correction: CD69 Is a TGF-β/1α,25-dihydroxyvitamin D3Target Gene in Monocytes
  102. Leptin Receptor Is Up-regulated in Inflamed Human Dental Pulp
  103. Role of Sam68 in Post-Transcriptional Gene Regulation
  104. Adiponectin Impairs Chicken Preadipocytes Differentiation through p38 MAPK/ATF-2 and TOR/p70 S6 Kinase Pathways
  105. Effective treatment of pulmonary tuberculosis restores plasma leptin levels
  106. Altered Regulation of ELAVL1/HuR in HLA-B27–Expressing U937 Monocytic Cells
  107. Insulin Enhances Leptin Expression in Human Trophoblastic Cells1
  108. CD69 Is a TGF-β/1α,25-dihydroxyvitamin D3 Target Gene in Monocytes
  109. Activated Translation Signaling in Placenta from Pregnant Women with Gestational Diabetes Mellitus: Possible Role of Leptin
  110. New Insights into the Role of the Immune Microenvironment in Breast Carcinoma
  111. The Role of Insulin C-Peptide in the Coevolution Analyses of the Insulin Signaling Pathway: A Hint for Its Functions
  112. Leptin expression in healthy and inflamed human dental pulp
  113. The Alternative Epac/cAMP Pathway and the MAPK Pathway Mediate hCG Induction of Leptin in Placental Cells
  114. Correction: Exogenous Amino Acids Are Essential for Interleukin-7 Induced CD8 T Cell Gowth
  115. Increased Autophagy in Placentas of Intrauterine Growth-Restricted Pregnancies
  116. A Two-Step Screening, Measurement of HbA1c in Association with FPG, May Be Useful in Predicting Diabetes
  117. Exogenous Amino Acids Are Essential for Interleukin-7 Induced CD8 T Cell Gowth
  118. Regulation of leptin expression by 17beta-estradiol in human placental cells involves membrane associated estrogen receptor alpha
  119. Elsevier Trophoblast Research Award Lecture: Molecular mechanisms underlying estrogen functions in trophoblastic cells − Focus on leptin expression
  120. Sam68 interacts with IRS1
  121. Sam68 mediates leptin-stimulated growth by modulating leptin receptor signaling in human trophoblastic JEG-3 cells
  122. Review: Leptin gene expression in the placenta – Regulation of a key hormone in trophoblast proliferation and survival
  123. Evaluation of two HbA1c point-of-care analyzers
  124. Leptin receptor activation increases Sam68 tyrosine phosphorylation and expression in human trophoblastic cells
  125. Reprint of: Metabolic effects and mechanism of action of the chromogranin A-derived peptide pancreastatin
  126. Glycated hemoglobin vs. the oral glucose tolerance test for the exclusion of impaired glucose tolerance in high-risk individuals
  127. Regulation of Placental Leptin Expression by Cyclic Adenosine 5′-Monophosphate Involves Cross Talk between Protein Kinase A and Mitogen-Activated Protein Kinase Signaling Pathways
  128. 17Beta-Estradiol Enhances Leptin Expression in Human Placental Cells Through Genomic and Nongenomic Actions1
  129. MAPK and PI3K activities are required for leptin stimulation of protein synthesis in human trophoblastic cells
  130. Blocking of melatonin synthesis and MT1 receptor impairs the activation of Jurkat T cells
  131. Metabolic effects and mechanism of action of the chromogranin A-derived peptide pancreastatin
  132. Role of Leptin in the Activation of Immune Cells
  133. Leptin Stimulates Protein Synthesis-Activating Translation Machinery in Human Trophoblastic Cells1
  134. Oleoylethanolamide, a natural ligand for PPAR-alpha, inhibits insulin receptor signalling in HTC rat hepatoma cells
  135. P-62: Role of phosphatidylinositol-3-kinase and S6 kinase in insulin-stimulated glycogen synthesis
  136. P-78: Role of p85 isoforms of phosphatidylinositol-3-kinase in insulin receptor signaling
  137. Up-Regulation of Placental Leptin by Human Chorionic Gonadotropin
  138. Role of Leptin in the Immune System
  139. Leptin prevents apoptosis of trophoblastic cells by activation of MAPK pathway
  140. Use of Point-of-Care-Testing Glucose Meters in the Oral Glucose Tolerant Test
  141. Profile of Patients Triply Infected with HIV and the Hepatitis B and C Viruses in the HAART Era
  142. Resultados de la implantación de un sistema de control de calidad para los glucómetros del Área Hospitalaria Virgen Macarena, con conexión on-line al Laboratorio de Bioquímica Clínica, durante el período 2003–2007,
  143. Leptin promotes cell survival and activates Jurkat T lymphocytes by stimulation of mitogen-activated protein kinase
  144. Leptin Promotes Cell Proliferation and Survival of Trophoblastic Cells1
  145. Regulation of the Immune Response by Leptin
  146. Signalling mechanisms regulating lipolysis
  147. Hyperhomocysteinemia correlates with insulin resistance and low-grade systemic inflammation in obese prepubertal children
  148. Pancreastatin: Multiple Actions on Human Intermediary Metabolismin Vivo, Variation in Disease, and Naturally Occurring Functional Genetic Polymorphism
  149. Sam68 is tyrosine phosphorylated and recruited to signalling in peripheral blood mononuclear cells from HIV infected patients
  150. Oleylethanolamide impairs glucose tolerance and inhibits insulin-stimulated glucose uptake in rat adipocytes through p38 and JNK MAPK pathways
  151. Homocysteine thiolactone inhibits insulin-stimulated DNA and protein synthesis: possible role of mitogen-activated protein kinase (MAPK), glycogen synthase kinase-3 (GSK-3) and p70 S6K phosphorylation
  152. eNOS, nNOS, cGMP and protein kinase G mediate the inhibitory effect of pancreastatin, a chromogranin A-derived peptide, on growth and proliferation of hepatoma cells
  153. Educational intervention together with an on-line quality control program achieve recommended analytical goals for bedside blood glucose monitoring in a 1200-bed university hospital
  154. Role of Sam68 as an adaptor protein in signal transduction
  155. Pancreastatin, A Regulatory Peptide that Modulates Energy Metabolism
  156. Marcadores biológicos de inflamación vascular y aterosclerosis subclínica en el síndrome metabólico
  157. Marcadores biológicos de inflamación vascular y aterosclerosis subclínica en el síndrome metabólico
  158. Expression of activation molecules in neutrophils, monocytes and lymphocytes from patients with unstable angina treated with stent implantation
  159. Pancreastatin, a chromogranin A-derived peptide, inhibits leptin and enhances UCP-2 expression in isolated rat adipocytes
  160. Leptin stimulates the oxidative burst in control monocytes but attenuates the oxidative burst in monocytes from HIV-infected patients
  161. Role of leptin as an immunomodulator of blood mononuclear cells: mechanisms of action
  162. The expression of Sam68, a protein involved in insulin signal transduction, is enhanced by insulin stimulation
  163. Pancreastatin
  164. Pancreastatin Receptor Signaling
  165. Human leptin promotes survival of human circulating blood monocytes prone to apoptosis by activation of p42/44 MAPK pathway
  166. Pancreastatin, a chromogranin A-derived peptide, activates protein synthesis signaling cascade in rat adipocytes
  167. Leptin receptor (Ob-R) expression is induced in peripheral blood mononuclear cells byin vitroactivation andin vivoin HIV-infected patients
  168. Elevated plasma total homocysteine levels in hyperinsulinemic obese subjects
  169. Inflammatory Response to Coronary Stent Implantation in Patients with Unstable Angina
  170. Differential expression of a WD protein during squamous differentiation of tracheal epithelial cells
  171. Sam68 associates with the SH3 domains of Grb2 recruiting GAP to the Grb2‐SOS complex in insulin receptor signaling
  172. Pancreastatin, a Chromogranin-A-Derived Peptide, Inhibits Insulin-Stimulated Glycogen Synthesis by Activating GSK-3 in Rat Adipocytes
  173. Sam68 is a docking protein linking GAP and PI3K in insulin receptor signaling
  174. Human Leptin Activates PI3K and MAPK Pathways in Human Peripheral Blood Mononuclear Cells: Possible Role of Sam68
  175. Homocysteine thiolactone inhibits insulin signaling, and glutathione has a protective effect
  176. Pancreastatin, a chromogranin A-derived peptide, inhibits DNA and protein synthesis by producing nitric oxide in HTC rat hepatoma cells
  177. Human Leptin Signaling in Human Peripheral Blood Mononuclear Cells: Activation of the JAK-STAT Pathway
  178. Pancreastatin, a chromogranin A-derived peptide, activates Gα16 and phospholipase C-β2 by interacting with specific receptors in rat heart membranes
  179. Pancreastatin modulates insulin signaling in rat adipocytes: mechanisms of cross-talk.
  180. Characterization of pancreastatin receptor and signaling in rat HTC hepatoma cells
  181. Affinity Purification of Pancreastatin Receptor–Gq/11 Protein Complex from Rat Liver Membranes
  182. Stimulation of glycogen synthesis by insulin requires S6 kinase and phosphatidylinositol-3-kinase in HTC-IR cells
  183. Human Leptin Enhances Activation and Proliferation of Human Circulating T Lymphocytes
  184. Characterization of pancreastatin receptors and signaling in adipocyte membranes
  185. p68 Sam is a substrate of the insulin receptor and associates with the SH2 domains of p85 PI3K
  186. G protein Gαq11 and Gαi1,2 are activated by pancreastatin receptors in rat liver: Studies with GTP‐γ35S and azido‐GTP‐α‐32P
  187. Human Leptin Stimulates Proliferation and Activation of Human Circulating Monocytes
  188. Modulation of insulin receptor signalling by pancreastatin in HTC hepatoma cells
  189. Insulin activates Gαil,2 protein in rat hepatoma (HTC) cell membranes
  190. Pancreastatin inhibits insulin action in rat adipocytes
  191. Increased plasma pancreastatin-like levels in gestational diabetes: correlation with catecholamine levels.
  192. Pancreastatin activates β3 isoform of phospholipase C via Gα11 protein stimulation in rat liver membranes
  193. Pancreastatin receptor is coupled to a guanosine triphosphate-binding protein of the Gg/11α family in rat liver membranes
  194. Normal pancreastatin-like and increased post-glucose insulin levels in young offspring of insulin-resistant non-obese essential hypertensive patients
  195. Solubilization and Molecular Characterization of Active Pancreastatin Receptors from Rat Liver Membranes1
  196. Solubilization and Molecular Characterization of Active Pancreastatin Receptors from Rat Liver Membranes
  197. Pancreastatin Signaling in the Liver
  198. Pancreastatin: further evidence for its consideration as a regulatory peptide
  199. Pancreastatin action in the liver: Dual coupling to different G proteins
  200. A Chemiluminescence Method to Analyze Phosphatidylcholine–Phospholipase Activity in Plasma Membrane Preparations and in Intact Cells
  201. Protein kinase C involvement in apoptosis
  202. Plasma pancreastatin-like immunoreactivity correlates with plasma norepinephrine levels in essential hypertension
  203. Role of p85 subunit of phosphatidylinositol-3-kinase as an adaptor molecule linking the insulin receptor to insulin receptor substrate 1
  204. Insulin-like growth factor-1 stimulation of cells induces formation of complexes containing phosphatidylinositol-3-kinase, guanosine triphosphatase-activating protein (GAP), and p62 GAP-associated protein.
  205. Pancreastatin activates protein kinase C by stimulating the formation of 1,2-diacylglycerol in rat hepatocytes
  206. Role of Phosphatidylinositol-3-Kinase in Insulin Receptor Signaling: Studies with Inhibitor, LY294002
  207. Pancreastatin activates pertussis toxin‐sensitive guanylate cyclase and pertussis toxin‐insensitive phospholipase C in rat liver membranes
  208. Pancreastatin inhibits insulin-stimulated glycogen synthesis but not glycolysis in rat hepatocytes
  209. Protein kinase C activation promotes cell survival in mature lymphocytes prone to apoptosis
  210. Sensitivity of Insulin-Secreting RIN m5F Cells to Undergoing Apoptosis by the Protein Kinase C Inhibitor Staurosporine
  211. Pancreastatin increases free cytosolic Ca2+ in rat hepatocytes, involving both pertussis-toxin-sensitive and -insensitive mechanisms
  212. Pancreastatin (33–49) enhances the priming effect of glucose in the rat pancreas
  213. Pancreastatin decreases plasma epinephrine levels in surgical stress in the rat
  214. Pancreastatin increases cytosolic Ca2+ in insulin secreting RINm5F cells
  215. Pancreastatin and its 33–49 C-terminal fragment inhibit glucagon-stimulated insulin in vivo
  216. Glycogenolytic effect of pancreastatin in isolated rat hepatocytes is mediated by a cyclic-AMP-independent Ca2+-dependent mechanism
  217. Decreased protein kinase C activity is associated with programmed cell death (apoptosis) in freshly isolated rat hepatocytes
  218. Glycogenolytic effect of vasoactive intestinal peptide in the rat in vivo
  219. Glycogenolytic effect of pancreastatin in the rat
  220. Pancreastatin
  221. Pancreastatin
  222. Purification of Pancreastatin Receptor from Rat Liver Membranes